MD2827F1 - Metoda de profilaxie a hiperplaziilor dishormonale ale glandei mamare - Google Patents

Metoda de profilaxie a hiperplaziilor dishormonale ale glandei mamare Download PDF

Info

Publication number
MD2827F1
MD2827F1 MDA20050061A MD20050061A MD2827F1 MD 2827 F1 MD2827 F1 MD 2827F1 MD A20050061 A MDA20050061 A MD A20050061A MD 20050061 A MD20050061 A MD 20050061A MD 2827 F1 MD2827 F1 MD 2827F1
Authority
MD
Moldova
Prior art keywords
prophylaxis
hyperplasiae
dishormonal
mammary
gynecological
Prior art date
Application number
MDA20050061A
Other languages
English (en)
Other versions
MD2827G2 (ro
Inventor
Mihail SURGUCI
Original Assignee
Mihail SURGUCI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mihail SURGUCI filed Critical Mihail SURGUCI
Priority to MDA20050061A priority Critical patent/MD2827G2/ro
Publication of MD2827F1 publication Critical patent/MD2827F1/ro
Publication of MD2827G2 publication Critical patent/MD2827G2/ro

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Inventia se refera la medicina, in special la ginecologie si poate fi utilizata pentru profilaxia hiperplaziilor dishormonale la pacientele cu maladii ginecologice si neginecologice asociate. Esenta inventiei consta in aceea ca se administreaza preparate ce contin fitoestrogeni, si anume ulei din seminte de in, care se administreaza cate o capsula a cate 66 mg, de 2...3 ori pe zi, iar cura de tratament constituie 4 luni. ŕ
MDA20050061A 2005-03-04 2005-03-04 Metodă de profilaxie a hiperplaziilor dishormonale ale glandei mamare MD2827G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050061A MD2827G2 (ro) 2005-03-04 2005-03-04 Metodă de profilaxie a hiperplaziilor dishormonale ale glandei mamare

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050061A MD2827G2 (ro) 2005-03-04 2005-03-04 Metodă de profilaxie a hiperplaziilor dishormonale ale glandei mamare

Publications (2)

Publication Number Publication Date
MD2827F1 true MD2827F1 (ro) 2005-08-31
MD2827G2 MD2827G2 (ro) 2006-04-30

Family

ID=34859184

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050061A MD2827G2 (ro) 2005-03-04 2005-03-04 Metodă de profilaxie a hiperplaziilor dishormonale ale glandei mamare

Country Status (1)

Country Link
MD (1) MD2827G2 (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3041G2 (ro) * 2005-10-07 2006-12-31 Ион МЕРЕУЦЭ Metodă de profilaxie a displaziei dishormonale a glandei mamare
MD65Z (ro) * 2009-04-23 2010-03-31 Виталие МАКИДОН Metodă de tratament neinvaziv al fibroadenomului glandei mamare

Also Published As

Publication number Publication date
MD2827G2 (ro) 2006-04-30

Similar Documents

Publication Publication Date Title
Tilwe et al. Efficacy and tolerability of oral enzyme therapy as compared to diclofenac in active osteoarthrosis of knee joint: an open randomized controlled clinical trial
BR9916224A (pt) Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
UY30535A1 (es) Composicion comprendiendo farmacos antirretrovirales y al menos un polimero insoluble en agua, proceso de preparacion y aplicaciones.
UA94734C2 (ru) ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ
WO2004112711A3 (en) Oral extended-release composition
MA31668B1 (fr) Polypeptides, domaines variables d'anticorps et antagonistes
AR062167A1 (es) Sistema de administracion gastrorretentivo
CR20210376A (es) COMPUESTOS Y USO PARA EL TRATAMIENTO DE LA DEFICIENCIA DE a1-ANTITRIPSINA
CL2004000899A1 (es) Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
MX2019008489A (es) Tratamiento que comprende la administracion oral o gastrica de edaravona.
ECSP066608A (es) Suspensiones acuosas de ciclesonide para nebulización
SE0300098D0 (sv) Use of cyclin D1 inhibitors
ES2186576A1 (es) Acido 2-hidroxioleico para utilizar como medicamento.
MX2019008482A (es) Tratamiento medico que comprende administracion enteral de edaravona.
MD2827F1 (ro) Metoda de profilaxie a hiperplaziilor dishormonale ale glandei mamare
ATE458471T1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
MD3477F1 (ro) Metoda de tratament al hepatitei virale cronice C
CO2025007626A2 (es) Composiciones farmacéuticas para administración ocular
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
Shetty et al. Antimicrobial efficacy of curcumin modified zinc oxide eugenol against endodontic pathogens
EA201290378A1 (ru) Композиции, содержащие нестероидные противовоспалительные лекарственные средства
MX2007004104A (es) Uso de aceite de lavanda para la profilaxis y el tratamiento de neurastenia, problemas de somatizacion y otras enfermedades asociadas con la tension.
MD3619F1 (ro) Remediu medicamentos nazal cu actiune anticongestiva

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees